http://www.unboundmedicine.com/medline/ebm/research/antineoplasticsUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19894050/full_citation/Amyloid_in_bone_marrow_smears_of_patients_affected_by_multiple_myeloma_Petruzziello F, Zeppa P, Catalano L, et al. 
Amyloid in bone marrow smears of patients affected by multiple myeloma. [JOURNAL ARTICLE]
Ann Hematol 2009 Nov 6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891101/full_citation/[Pharmacogenetics_of_antineoplastic_agents_designed_for_malignant_cancers]Minami H 
[Pharmacogenetics of antineoplastic agents designed for malignant cancers] [Journal Article]
Nippon Naika Gakkai Zasshi 2009 Aug 10; 98(8):1846-53.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19886359/full_citation/[Evaporation_of_selected_cytotoxic_drugs_and_permeation_of_protective_gloves__research_into_the_occupational_risks_of_health_care_personnel_handling_hazardous_cytotoxic_drugs__CYTO_project_]Dolezalová L, Odráska P, Gorná L, et al. 
[Evaporation of selected cytotoxic drugs and permeation of protective gloves--research into the occupational risks of health care personnel handling hazardous cytotoxic drugs (CYTO project)] [English Abstract, Journal Article]
Klin Onkol 2009; 22(5):218-22.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19879139/full_citation/Synthesis_of_fluorescent_C_24__ceramide:_Evidence_for_acyl_chain_length_dependent_differences_in_penetration_of_exogenous_NBD_ceramides_into_human_skin_Novotný J, Pospěchová K, Hrabálek A, et al. 
Synthesis of fluorescent C(24)-ceramide: Evidence for acyl chain length dependent differences in penetration of exogenous NBD-ceramides into human skin. [JOURNAL ARTICLE]
Bioorg Med Chem Lett 2009 Oct 15.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19877310/full_citation/Hearing_improvement_after_bevacizumab_for_neurofibromatosis_type_2_Diao JS, Xia WS, Guo SZ 
Hearing improvement after bevacizumab for neurofibromatosis type 2. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1810; author reply 1810-1.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19875955/full_citation/Estrogen_Receptor_Progesterone_Receptor_and_Glucocorticoid_Receptor_Expression_in_Normal_Breast_Tissue_Breast_In_Situ_Carcinoma_and_Invasive_Breast_Cancer_Buxant F, Engohan-Aloghe C, Noël JC 
Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer. [JOURNAL ARTICLE]
Appl Immunohistochem Mol Morphol 2009 Oct 28.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19875124/full_citation/On_line_solid_phase_extraction_of_large_volume_injections_coupled_to_liquid_chromatography_tandem_mass_spectrometry_for_the_quantitation_and_confirmation_of_14_selected_trace_organic_contaminants_in_drinking_and_surface_water_Garcia-Ac A, Segura PA, Viglino L, et al. 
On-line solid-phase extraction of large-volume injections coupled to liquid chromatography-tandem mass spectrometry for the quantitation and confirmation of 14 selected trace organic contaminants in drinking and surface water. [JOURNAL ARTICLE]
J Chromatogr A 2009 Oct 12.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19866543/full_citation/IL_2_immunotherapy_does_not_benefit_patients_taking_antiretrovirals_IL-2 immunotherapy does not benefit patients taking antiretrovirals. [News]
AIDS Patient Care STDS 2009 Mar; 23(3):221-2.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19864683/full_citation/Hearing_improvement_after_bevacizumab_for_neurofibromatosis_type_2_Guntinas-Lichius O 
Hearing improvement after bevacizumab for neurofibromatosis type 2. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1809-10; author reply 1810-1.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19864682/full_citation/Peginterferon_alfa_2b_or_alfa_2a_with_ribavirin_for_hepatitis_C_Hsu CS, Kao JH 
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1808-9; author reply 1809.
Full Citation | Find Related Articles